Partner

Retail & Channel LAB has partnered with Agos to develop an Observatory dedicated to analyzing consumer trends in the Automotive, Durable Goods and Retail sectors. 

Thus was born the Agos Retail Trend (ART), an incubator dedicated to the dynamic study of the main evolutionary trajectories related to international purchasing and consumption behaviors in the target markets, with the aim of deriving useful insights to be shared, on both the academic and the executive level, with SDA Bocconi and Agos partners. The contribution of main sponsors and partner companies to Retail & Channel LAB initiatives is essential to support the work of the center and to be able to have privileged access to the products of scientific research and management training made available by the LAB.

To check the manner and procedures necessary for collaboration, companies can get in touch with the Retail & Channel LAB at the following address:

SDA Bocconi's Channel and Retail LAB has entered into a collaboration with Singapore Management University's Retail Center of Excellence: the mission of this partnership is to develop joint study projects and share knowledge through the synergistic delivery of workshops and seminars, which can enable participants from both universities to come into direct contact with different consumer scenarios and approaches to business, as well as foster a valuable moment of international networking.

The Comifar Group, belonging to PHOENIX group, a European leader in healthcare distribution, is represented by three companies, with specific expertise of know-how and knowledge of the territory, acting in coordination to create a complete, efficient and integrated distribution system: Comifar Distribuzione S.p.A., active in peninsular Italy and Sicily, SPEM S.p.A., spread throughout the country, and Difarma S.p.A., operating in Sardinia. 

The Comifar Group today represents the largest local entity in the panorama of pharmaceutical distribution in Italy and, with the Valore Salute Network, acts as a privileged interlocutor between the pharmacy and the citizen, to raise the latter's awareness of the concept of prevention and informed health. True to its corporate philosophy of "Building business value through sustainable growth", Comifar offers customers and industry partners flexible solutions along the entire value chain, thus contributing to their success. Modular services, business intelligence, consulting and new product launch support (branded and generic), as well as supply chain solutions, trade marketing, category management, marketing services and affiliate programs: Comifar can meet any need and solve any problem. Comifar offers all clients specific marketing and sales services, as well as advanced information technology solutions that support the pharmacy's growth and enable it to meet the needs of the modern consumer. 

Technology, logistics, quality and assortment have been decisive factors in making it the leading distribution company in Italy, but Comifar's greatest value lies in the staff of its employees and collaborators, who materialize the Group's success. The strong drive for innovation, the accuracy of the services provided and the punctuality of deliveries are the fruit of the daily commitment of Comifar men and women - the Group's greatest asset.

Digital Solutions has always been committed to developing projects, including through its other group companies, that help industry build trusted relationships with target groups (patients, pharmacists, physicians, institutions). In recent years, it has focused and is investing heavily in building go-to-market projects tailored to fit the needs of the industry. Backed by a network of 10,000 pharmacies that systematically adhere to the proposed trade marketing programs and a timely and reliable reward system, Digital Solutions is the leading provider of marketing contributions in the pharmacy channel. This gives it a particularly high engagement rate. The industry also relies on effective performance monitoring systems that ensure it invests only where there is full adherence to the proposed activity. 

From product launches to the placement of materials in pharmacies, from surveys to the use of product training pills by pharmacy staff, from sales targets to the engagement of patient communities, whatever performance the Industry wants to achieve, Digital Solutions custom-builds the entire process (including technology) best suited to achieve it, leaving nothing out: from the dashboard for the sales force, to the profiling of target pharmacies, from methodical checks of effective adherence to the call center service for agents and pharmacies to the rewarding of the pharmacy or its staff. All with the aim of reducing costs, increasing the speed and effectiveness of its client companies' go-to-market. Digital Solutions systematically evaluates and invests in innovation start-ups in the channel, aiming to intercept new ways to narrow the gap between the industry and the market.

Teva, founded in 1901 in Jerusalem, Teva is now among the top 15 pharmaceutical companies in the world. Having become a world leader in generic drugs, in part through several successful acquisitions, it has also strengthened its expertise in innovative medicines, expanding its business into new therapeutic areas and new markets. Today Teva distributes drugs to hospitals and pharmacies in more than 60 markets around the world, employing more than 40,000 people, to ensure access to care for more than 200 million patients every day. 

Teva develops and manufactures active pharmaceutical ingredients, generic drugs, innovative drugs and self-medication products by investing in production and R&D processes both innovative and dedicated also to the generic drug while meeting the strict quality standards required by international and local regulatory bodies. With more than 1,800 molecules worldwide, Teva offers the broadest portfolio of high-quality drugs covering all therapeutic areas. 

In Italy, Teva has been present since 1996, and is a leader in generic drugs (in Italy 1 in 4 generic drugs dispensed in pharmacies is a Teva product), with a continuous growth of the supply that responds to new treatment needs: innovative, sustainable, but also and above all patient-friendly. Precisely for this reason, Teva has also improved the graphics of its medication packages to make them even clearer and more complete, to help patients take their medications even more correctly and consciously.

Chiesi Italia is the Italian subsidiary of the Chiesi Group, the largest international pharmaceutical group certified B Corp The history of the Chiesi Group stems from one family's commitment to improving the quality and health of people. It was born in Parma in 1935 with Giacomo Chiesi, who began his research activities. In 1955 it added a manufacturing plant, and shortly after, the company began to forge relationships with international entities. To date, the group operates in 30 countries. In this evolution, Chiesi Italia, the Group's Italian subsidiary, has followed the growth in the Italian market, in which it markets Chiesi products and carries out scientific information activities. 

Chiesi represents one of the most important pharmaceutical companies internationally, thanks to a strong focus on research and innovation. Three pillars on which the commitment to patients is based: AIR, therapeutic solutions and services dedicated to the respiratory area; RARE, treatments for patients with rare diseases; CARE, products and services to support specialized care and personal care and wellness products provided by health professionals. 

Innovation is the driving force behind every technologically advanced industry, but in the pharmaceutical field it gains special importance as it affects the health and quality of life of patients. For Chiesi, together with R&D, it represents a real human and technological asset, as well as being the engine of its growth.

Haleon (LSE: HLN), a company established in July 2022 and dedicated entirely to everyday health products, is a global leader in Consumer Healthcare, with brands that garner the trust of millions of people around the world. The group employs more than 22,000 employees in 170 countries, united by a common purpose: to provide better everyday health, with humanity. 

Haleon's product portfolio includes five main categories: oral health, pain relief, respiratory health and digestive health, as well as vitamins, minerals and supplements (VMS). We have a portfolio of world-class heritage brands -including Sensodyne, Parodontax, Polident, Voltaren, Rinazina, Multicentrum, Polase, BeTotal- supported by decades of experience in scientific research, innovation, and a deep understanding of people's needs. 

Haleon has an ambitious goal: we want to make everyday health more accessible, more inclusive, and more sustainable in the world by aiming to put 50 million people a year in a better position to meet their health needs by 2025. Italy plays a key role in this journey, as the most significant market in Mediterranean Europe in which Haleon has been present for decades, with its sales office in Milano and factory in Aprilia, which employs nearly 1,000 people and has a production capacity of more than 100 million packs per year. 

In a social and healthcare scenario that - especially after the outbreak of the Covid-19 pandemic - demands an ever-increasing focus on prevention, daily health and self-care, Haleon is a market leader thanks to a winning business model that reaches consumers with distribution across multiple sales channels (Pharmacy, Parapharmacy, Mass Retail, E-commerce).